Every now and then what seems like one player out in left field for the longest time suddenly balloons into a whole new class or niche of agents.

Such is the case for the target in the spotlight in today’s focused review.

Here we look at the challenges and opportunities provided within the emerging landscape, explore where the field is going, and what to watch out for because this is one you’re going to hear a lot more about going forward in a number of ways…

To learn more from our latest oncology expert interview and get a heads up on key cancer research insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by